Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Implementing zero based budgeting can significantly improve your cash flow. Explore its benefits for better financial health.
24,403 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
As rates cool, Angel Oak’s Hutchens charts a growth path for non-QM lending with a sharper focus on product expansion...
Geopolitical headlines, especially about Iran, push markets around in the short term. This guide helps long-term inve...
Strategy stock essentially leveraged means the company borrows to buy Bitcoin, making its fate closely tied to crypto...
A $1,000 investment in crypto can set you on a disciplined path rather than riding hype. This guide shows how to iden...
Analysts warn of a brutal bitcoin liquidation cascade if BTC slips below $59,000, citing concentrated long leverage a...
AI stocks surged on hype, not just earnings. Yet after robust results from taiwan semiconductor and ASML, the market ...
Kleiner Perkins is staging a revival in a cooler venture market after hiring an unexpected partner. The move aims to ...
A new memoir and interview place Lloyd Blankfein at the center of a renewed debate over risk, accountability, and how...
Commercial Metals posted a blowout quarter in Q2 2026, with revenue hitting $2.132 billion and net income of $93 mill...
Bitcoin has shown extreme volatility but a history of rebound. This piece weighs the long-term case for newcomers, wi...
Tod Boehly argues that admitting uncertainty is a strength in an AI-powered era. This guide explores what that means ...